X-150987884-AGAGGAG-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_005342.4(HMGB3):c.591_596delGGAGGA(p.Glu197_Glu198del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000178 in 1,176,973 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 61 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00023 ( 0 hom., 5 hem., cov: 22)
Exomes 𝑓: 0.00017 ( 0 hom. 56 hem. )
Consequence
HMGB3
NM_005342.4 disruptive_inframe_deletion
NM_005342.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.34
Genes affected
HMGB3 (HGNC:5004): (high mobility group box 3) This gene encodes a member of a family of proteins containing one or more high mobility group DNA-binding motifs. The encoded protein plays an important role in maintaining stem cell populations, and may be aberrantly expressed in tumor cells. A mutation in this gene was associated with microphthalmia, syndromic 13. There are numerous pseudogenes of this gene on multiple chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant X-150987884-AGAGGAG-A is Benign according to our data. Variant chrX-150987884-AGAGGAG-A is described in ClinVar as [Likely_benign]. Clinvar id is 3033754.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Hemizygotes in GnomAd4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMGB3 | NM_005342.4 | c.591_596delGGAGGA | p.Glu197_Glu198del | disruptive_inframe_deletion | 5/5 | ENST00000325307.12 | NP_005333.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMGB3 | ENST00000325307.12 | c.591_596delGGAGGA | p.Glu197_Glu198del | disruptive_inframe_deletion | 5/5 | 1 | NM_005342.4 | ENSP00000359393.3 | ||
HMGB3 | ENST00000448905.6 | c.591_596delGGAGGA | p.Glu197_Glu198del | disruptive_inframe_deletion | 5/5 | 1 | ENSP00000442758.1 | |||
HMGB3 | ENST00000419110.5 | c.*8_*13delGAGGAG | downstream_gene_variant | 3 | ENSP00000410354.1 |
Frequencies
GnomAD3 genomes AF: 0.000234 AC: 26AN: 111043Hom.: 0 Cov.: 22 AF XY: 0.000150 AC XY: 5AN XY: 33297
GnomAD3 genomes
AF:
AC:
26
AN:
111043
Hom.:
Cov.:
22
AF XY:
AC XY:
5
AN XY:
33297
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000213 AC: 36AN: 169187Hom.: 0 AF XY: 0.000115 AC XY: 7AN XY: 60757
GnomAD3 exomes
AF:
AC:
36
AN:
169187
Hom.:
AF XY:
AC XY:
7
AN XY:
60757
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000172 AC: 183AN: 1065930Hom.: 0 AF XY: 0.000162 AC XY: 56AN XY: 344662
GnomAD4 exome
AF:
AC:
183
AN:
1065930
Hom.:
AF XY:
AC XY:
56
AN XY:
344662
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000234 AC: 26AN: 111043Hom.: 0 Cov.: 22 AF XY: 0.000150 AC XY: 5AN XY: 33297
GnomAD4 genome
AF:
AC:
26
AN:
111043
Hom.:
Cov.:
22
AF XY:
AC XY:
5
AN XY:
33297
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
HMGB3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 02, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at